About TATAA Biocenter
TATAA Biocenter is a company based in Goteborg (Sweden) founded in 2001. TATAA Biocenter has completed 1 acquisition, including Life Genomics. TATAA Biocenter offers products and services including qPCR/dPCR Assays, RNA Sequencing, DNA Sequencing, and Biomarker Analysis. TATAA Biocenter operates in a competitive market with competitors including Tessera Therapeutics, Phase Genomics, Hexagon Bio, NovellusDx and BGI, among others.
- Headquarter Goteborg, Sweden
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bio Center S.R.O.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$27.43 K (USD), Grant
Dec 01, 2023
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TATAA Biocenter
TATAA Biocenter offers a comprehensive portfolio of products and services, including qPCR/dPCR Assays, RNA Sequencing, DNA Sequencing, and Biomarker Analysis.
Quantify biomarkers and genetic targets for drug development applications
Provides sequencing from extraction to analysis for research needs
Sequences genomes and panels to identify genetic variations
Analyzes molecular biomarkers in biological samples
Funding Insights of TATAA Biocenter
Investors in TATAA Biocenter
TATAA Biocenter has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for TATAA Biocenter
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TATAA Biocenter
TATAA Biocenter has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Life Genomics.
Investment portfolio details for TATAA Biocenter
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Genetic tests for fetal health and personal wellness are developed.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for TATAA Biocenter
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - TATAA Biocenter
Detailed financials for TATAA Biocenter
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tataa Biocenter Comparisons
Peer comparison for TATAA Biocenter
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TATAA Biocenter
TATAA Biocenter operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tessera Therapeutics, Phase Genomics, Hexagon Bio, NovellusDx and BGI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
New genome engineering technology is provided for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Laboratory and computational services for DNA proximity analysis are provided.
|
|
| Locked | Locked | Locked |
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
|
|
| Locked | Locked | Locked |
Developer of technology for precision cancer diagnosis and therapies
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
Detailed competitors of TATAA Biocenter
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tataa Biocenter
Complete news archive for TATAA Biocenter
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TATAA Biocenter
TATAA Biocenter was founded in 2001 and raised its 1st funding round 12 years after it was founded.
TATAA Biocenter is headquartered in Goteborg, Sweden. It is registered at Goteborg, Vastra Gotaland, Sweden.
TATAA Biocenter was founded in 2001 in Gothenburg, Sweden, and operates as a contract research organization in the pharmaceutical sector. Bioanalytical services are provided to support scientific research, clinical trials, and drug development. A range of molecular analysis techniques is utilized, including PCR services, next-generation sequencing, and proteomics. Operations focus on assisting pharmaceutical companies with analytical needs in a regulated environment.
TATAA Biocenter's top competitors include Tessera Therapeutics, Phase Genomics and BGI.
TATAA Biocenter offers qPCR/dPCR Assays, RNA Sequencing, DNA Sequencing, and Biomarker Analysis.
TATAA Biocenter has made 1 acquisition, including Life Genomics.
TATAA Biocenter has 1 investor. Key investors include European Union.